Abstract
Aim: To compare outcomes of coronary computed tomography angiography (CCTA) with that of functional testing (FT) in stable coronary artery disease. Methods: We searched PubMed, Embase, and Cochrane for randomized controlled trials (RCTs). A random-effects meta-analysis targeting all-cause death and nonfatal acute coronary syndromes was performed. Results: Eight RCTs enrolling 29,579 patients were included. Pooled relative risk (RR) for the primary end point was similar between CCTA and FT (RR = 0.97; 95% CI: 0.76-1.22). CCTA outperformed FT in nonfatal myocardial infarction (MI) (RR = 0.59; 95% CI: 0.41-0.83) and in downstream testing (OR: 0.47; 95% CI: 0.21-1.01). Conclusion: Updated data of stable coronary artery disease suggests that CCTA improved nonfatal MI and downstream testing.
| Original language | English |
|---|---|
| Pages (from-to) | 407-416 |
| Number of pages | 10 |
| Journal | Future Cardiology |
| Volume | 18 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2022 |
| Externally published | Yes |
Keywords
- coronary artery disease
- coronary computed tomography angiography
- myocardial infarction
Fingerprint
Dive into the research topics of 'Computed tomography coronary angiography as the noninvasive in stable coronary artery disease? Long-term outcomes meta-analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver